Why Amedisys Shares Slumped 24.6% in July
Amedisys Inc. (NASDAQ: AMED) shares lost nearly 25% of their value last month, according to S&P Global Market Intelligence. The drop was caused by word that the the federal government's Centers for Medicare and Medicaid Services (CMS) may cut reimbursement for home healthcare by 0.4% next year and redesign its payment scheme altogether in 2019.
Home healthcare providers rely heavily on Medicare for their revenue, and that means share prices can pop or drop depending on the payment proposals issued by the agency, which operates under the Department of Health and Human Services.
IMAGE SOURCE: GETTY IMAGES.
Source: Fool.com
Amedisys Inc. Aktie
89,00 €
-
Die Community zeigt eindeutige Unterstützung für Amedisys Inc. mit mehreren Buy-Einschätzungen und keinen Sell-Einschätzungen.
Ein positives Kurspotenzial für Amedisys Inc. ist gegeben, mit einem Kursziel von 92 € über dem aktuellen Kurs von 89.0 €.
